EU Exit Planning: Non-Clinical Goods and Services

Thank you for responding to our recent survey on practice needs in the event of a no-deal Brexit. We rely on your input.
Following a discussion at our Annual General Meeting on Thursday 24 January, we asked you about the impact of a no-deal EU exit on your practice-critical Non-Clinical Goods and Services (NCGS). Medical devices, clinical consumables and medicines are being considered separately.

We asked you to consider:

  • The dependency of those goods/ services on that front-line service;
  • The criticality of that front-line service and its clinical importance; and
  • Outsourced services such as equipment maintenance.

We had a really good response and have been able to advise officials about supply concerns across London in good time. Whilst there were a number of respondents who are unconcerned about the impact of no-deal Brexit, those who do harbour concerns highlighted a number of non clinical products and services which they fear might be affected. These include:

  • Stationary;
  • Printer ink;
  • Prescription pads;
  • Couch roll;
  • Paper;
  • Telephony;
  • Cleaning products;
  • Prescription paper;
  • Printer;
  • Hand towels;
  • Testing;
  • Telephone systems;
  • Practice cleaning products; and
  • Toner.

We will continue to work with officials to identify and anticipate the impact of Brexit on London general practice, be it no-deal or otherwise. Other possible EU exit risks include: 

  • Goods or services that have supply chain touch points in the EU;
  • Personal data held in EU member countries;
  • Supply routes into the UK via Dover/ Calais; and
  • Dependencies on EU regulations.

If you have any comments or questions about this work, please contact us.

This word cloud gives some indication of respondents' concerns.

Last updated : 20 Mar 2019

 

Latest LMC workforce survey - please complete our short survey by Friday 17 December 2021 (25 Nov 2021)

We have extended the closing date of our workforce survey to 17:00 on Friday 17 December, in recognition of the substantial time pressures on practices. Please do still take 10...
Read more »

Help us respond to the Health and Social Care Select Committee enquiry into ‘The Future of General Practice’ (25 Nov 2021)

We will be responding to this new inquiry as on behalf of London general practice and would welcome your views. We will highlight London GP teams’ commitment to patient access,...
Read more »

New Integrated Care Board CEOs (23 Nov 2021)

The five chief executive roles for London’s Integrated Care Boards (ICBs) have been appointed. They are: North West London: Rob Hurd, current North Central London ICS Joint Executive lead. North...
Read more »

Update: GP earnings declarations delayed until at least next Spring (22 Nov 2021)

Last week we were informed by the General Practitioners Committee England (GPC England) of the BMA that they had further discussions with the Department of Health and Social Care (DHSC)...
Read more »

Londonwide LMCs' Buying Group - flu vaccine offer (03 Nov 2021)

The Londonwide LMCs’ Buying Group offers discounted rates on flu vaccines via our buying group supplier MidMeds. Member practices should call Mylan (0800 358 7468), or Seqirus (08457 451 500),...
Read more »

Covid-19 guidance update – October 2021 (20 Oct 2021)

This page collates new guidance and existing guidance that has been updated since our last newsletter on 22 September. Covid-19 vaccination programme Covid-19 vaccination deployment next steps for...
Read more »

Tips of the Month October 2021 (20 Oct 2021)

We provide monthly tips based on common queries which come through to us from London GPs and practice teams. These are shared via social media and collated for...
Read more »
Next Page »
« Previous Page